ablukast
Sign in to saveAblukast (INN) is an experimental drug that is a leukotriene antagonist. It was investigated for potential applications in the treatment of inflammatory conditions, including asthma, skin disorders, and inflammatory bowel disease. It reached Phase III clinical trials, but development was discontinued in 1996.
Wikidata facts
- Mass
- 498.225
Show 3 more facts
- canonical SMILES
- CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCCOC2=CC3=C(CCC(O3)C(=O)O)C=C2C(=O)C
- chemical formula
- C₂₈H₃₄O₈
- Commons category
- Ablukast
Sources (2)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- References
- External links
Ablukast (INN) is an experimental drug that is a leukotriene antagonist. It was investigated for potential applications in the treatment of inflammatory conditions, including asthma, skin disorders, and inflammatory bowel disease. It reached Phase III clinical trials, but development was discontinued in 1996.
==References==
Connections
medication
Entity
enzyme
Entity
digital object identifier
Entity
chemical formula
Entity
dermatology
Entity
Hypericum perforatum
Entity
molar mass
Entity
Q180686
Entity
CAS Registry Number
Entity
PubChem
Entity
Anatomical Therapeutic Chemical Classification System
Entity
signaling receptor
Entity
simplified molecular input line entry specification
Entity
arachidonic acid
Entity
linoleic acid
Entity
curcumin
Entity
Q2311683
Entity
IUPAC nomenclature of chemistry
Entity
cell signaling
Entity
captopril
Entity